alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE SHEET
AND STATEMENT OF OPERATIONS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          89,125
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                89,776
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  92,390
<CURRENT-LIABILITIES>                          127,906
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                    64,175,936
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                    92,390
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 8,500
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 370
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (91,648)
<EPS-BASIC>                                         .0
<EPS-DILUTED>                                       .0


</TABLE>
EXHIBIT 32.1







CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADDED BY

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of Little Squaw Gold Mining Company (the "Company") on Form 10-QSB for the period ended March 31, 2005 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Richard R. Walters, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.ss. 1350, as added by ss. 906 of the Sarbanes-Oxley Act of 2002, that:



(a)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(b)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.



A signed original of this written statement required by Section 906 has been provided to Little Squaw Gold Mining Company and will be retained by Little Squaw Gold Mining Company and furnished to the Securities and Exchange Commission or its staff upon request.



Date: May 13, 2005







By   /s/ Richard R. Walters



Richard R. Walters, President and Chief Executive Officer
**Exhibit10.2**

 

**MODIFICATION TO PROMISSORY NOTE**

 

WHEREAS, on July 3, 1995, Lee Pharmaceuticals(“maker”) and Sass DiSalvo (“Holder”) entered into an agreement (“Note”)whereby Lee Pharmaceuticals was to pay to Sass DiSalvo the sum of FiftyThousand Dollars; and

 

WHEREAS, on July 6, 1996, the parties thereto modifiedsaid Note to extend the maturity date from July 6, 1996, until December 8,1997, ( a copy of said Modification to Promissory Note is attached forreference as Exhibit A); and

 

WHEREAS, on December 8, 1997, the parties theretomodified said Note to extend the maturity date from December 8, 1997, untilDecember 1, 1998, (a copy of said Modification to Promissory Note is attachedfor reference as Exhibit B); and

 

WHEREAS, on December 1, 1998, the parties theretomodified said Note to extend the maturity date from December 1, 1998, untilJune 30, 1999, (a copy of said Modification to Promissory Note is attached forreference as Exhibit C); and

 

WHEREAS, on June 30, 1999, the parties theretomodified said Note to extend the maturity date from June 30, 1999, until June30, 2000, (a copy of said Modification to Promissory Note is attached forreference as Exhibit D); and

 

WHEREAS, on June 30, 2000, the parties theretomodified said Note to extend the maturity date from June 30, 2000, untilDecember 1, 2001, (a copy of said Modification to Promissory Note is attachedfor reference as Exhibit E); and

 

WHEREAS, on December 1, 2001, the parties theretomodified said Note to extend the maturity date from December 1, 2001, untilDecember 1, 2002, (a copy of said Modification to Promissory Note is attachedfor reference as Exhibit F); and

 

WHEREAS, on December 1, 2002, the parties theretomodified said Note to extend the maturity date from December 1, 2002, until December1, 2003, (a copy of said Modification to Promissory Note is attached forreference as Exhibit G; and

 

WHEREAS, the parties hereto now desire to furthermodify said Note and Modification;

 

NOW, THEREFORE, the parties modify said Note andModification as follows:

 

1.             Thematurity date of the Note is extended from December 1, 2003, until December 1,2004.

 

2.             Allother terms and conditions of the Note remain the same.

 

 

Date this  24TH  day of NOVEMER, 2003

 

----

 
|   |   |   |   |   |   | RONALD G. LEE                       |   |
|--------|--------|--------|--------|--------|--------|-------------------------------------|--------|
|   |   |   |   |   |   | Lee Pharmaceuticals                 |
|   |   |   |   |   |   | By:  Ronald  G. Lee, President |
|   |   |   |   |   |   |                                |
|   |   |   |   |   |   |                                |
|   |   |   |   |   |   | SASS DI SALVO                       |   |
|   |   |   |   |   |   | Sass DiSalvo                        |

 

----
sedh_ex41





  Exhibit 4.1











 



DESCRIPTION OF THE REGISTRANT’S SECURITIES



REGISTERED PURSUANT TO SECTION 12 OF THE



SECURITIES EXCHANGE ACT OF 1934


 


As of
March 30, 2020, SeD Intelligent Home Inc. has one class of
securities registered under Section 12 of the Securities Exchange
Act of 1934, as amended, our common stock.


 


Description
of our Common Stock


 


The
following description of our common stock is a summary and does not
purport to be complete. It is subject to and qualified in its
entirety by reference to our Articles of Incorporation and our
Bylaws, each of which are incorporated by reference as an exhibit
to the Annual Report on Form 10-K of which this Exhibit 4.1 is a
part. We encourage you to read our Articles of Incorporation, our
Bylaws and the applicable provisions of the Nevada Revised Statutes
for additional information.


 


Authorized
Capital Shares


 


SeD
Intelligent Home Inc. has authorized 1,000,000,000 shares of common
stock, $0.001 par value per share, of which 704,043,324 are issued
and outstanding.


 


Voting
Rights


 


Holders
of our common stock are entitled to one vote for each share held on
all matters submitted to a vote of our stockholders.


 


Dividend
Rights


 


Since
inception we have not paid any dividends on our common stock. We
currently do not anticipate paying any cash dividends in the
foreseeable future on our common stock. Although we intend to
retain our earnings, if any, to finance the growth of our business,
our board of directors will have the discretion to declare and pay
dividends in the future. Payment of dividends in the future will
depend upon our earnings, capital requirements, and other factors,
which our board of directors may deem relevant. Holders of our
common stock will have equal ratable rights to any dividends which
may be declared.


 


Liquidation
Rights


 


Holders
of our common stock will share ratably in all assets legally
available for distribution to our stockholders in the event of
liquidation, dissolution or winding up of our affairs.


 


Other
Rights and Preferences


 


Holders
of our common stock do not have preemptive, subscription or
conversion rights.


 


Listing


 


Our
common stock is not currently quoted, traded or listed on any
exchange.
### TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED MA Y 9, 2014

NO. 03

- 13

- 00570

- CV

Rodrick Walker and Donna Johnson, Appellant s

v.

Texas Home Step, LLC, Appellee

APPEAL FROM COUNTY COURT AT LAW NO. 1 OF TRAVIS COUNTY

BEFORE JUST ICES PURYEAR, GOODWI N, AND FIELD

DISMISSED FOR WANT OF PROSECUTION

-- OPINION BY JUSTICE PURYEAR

This is an appeal from the judgment signed by the tr i a l court on Au gust 16, 2013. Having

reviewed the record , the Court holds that Rodrick Walker and Donna Johnson ha ve not

prosecuted their appeal and did not comply with a notice from the clerk of this court. T he appeal

is thus subject to dismissal. Therefore, the Cour t dismisses the appeal for want of prosecution.

Walker and Johnson shall pay all costs relating to this appeal, both in this Court and the court

below.
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. 2089 Introduced in Senate (IS)]

<DOC>

116th CONGRESS
  1st Session
                                S. 2089

 To prohibit the labeling of certain opioid drugs recommending use for 
                        long-term chronic pain.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             July 11, 2019

Mr. Manchin (for himself and Mr. Braun) introduced the following bill; 
     which was read twice and referred to the Committee on Health, 
                     Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL

 
 To prohibit the labeling of certain opioid drugs recommending use for 
                        long-term chronic pain.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``FDA Opioid Labeling Accuracy Act''.

SEC. 2. LABELING PROHIBITION.

    (a) In General.--Notwithstanding any other provision of law, the 
Secretary of Health and Human Services (referred to in this Act as the 
``Secretary'') may not approve labeling for an extended release or 
long-acting opioid analgesic drug unless, as applicable--
            (1) the labeling provides that such drug is not intended 
        for the treatment of chronic pain, except in the case of--
                    (A) treatment of pain related to cancer;
                    (B) end-of-life care; or
                    (C) a prescriber determination that, with respect 
                to a particular patient, other non-opioid pain 
                management treatments are inadequate or inappropriate; 
                or
            (2) the labeling is consistent with the regulations 
        promulgated by the Secretary pursuant to subsection (b).
    (b) Study and Labeling Regulations.--
            (1) In general.--Not later than 1 year after the date of 
        enactment of this Act, the Secretary shall--
                    (A) conduct a study on the efficacy of opioid 
                analgesic drugs for long-term chronic pain management; 
                and
                    (B) based on such study, promulgate regulations 
                regarding the labeling for extended release or long-
                acting opioid analgesic drugs, as scientifically 
                appropriate.
            (2) Updates.--The Secretary may update the regulations 
        promulgated under paragraph (1)(B), as appropriate.
                                 <all>
```
_________________________________________ 

 

 

Order Michigan Supreme Court

Lansing, Michigan 

July 29, 2008 Clifford W. Taylor,

 Chief Justice 

136381 Michael F. Cavanagh 

Elizabeth A. Weaver 

Marilyn Kelly 

Maura D. Corrigan 

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff-Appellee, 

Robert P. Young, Jr. 

Stephen J. Markman,

 Justices 

v SC: 136381 

 COA: 283622 

Oakland CC: 05-203377-FH 

DANIEL MATT MAJEWSKI, 

Defendant-Appellant. 

_________________________________________/ 

On order of the Court, the application for leave to appeal the April 18, 2008 order 

of the Court of Appeals is considered, and it is DENIED, because we are not persuaded 

that the question presented should be reviewed by this Court. 

t0721 

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the 

foregoing is a true and complete copy of the order entered at the direction of the Court. 

July 29, 2008 

 Clerk
# Fourth Court of Appeals

**San Antonio, Texas**

December 22, 2014

No. 04

- 14

- 00891

- CR

IN RE Samuel ESPINOZA

Original Mandamus Proceeding 1

ORDER

Sitting: Sandee Bryan Marion, Justice

Marialyn Barnard, Justice

Rebeca C. Martinez, Justice

On December 19, 2014 , relator filed a pro se petition for writ of mandamus. The court

has considered relator’s petition and is of the opinion that relator is not entitled to the relief

sought. Accordingly, the petition for writ of mandamus is DENIED. See T EX

. R. A PP

. P. 52.8(a).

Relator’s request for leave to file the petit ion for writ of mandamus is DENIED AS MOOT. The

court’s opinion will issue at a later date.

It is so ORDERED on December 22, 2014

.

_____________________________ Marialyn Barnard, Justice

IN WITNESS WHEREOF, I have hereunt o set my hand and affixed the seal of the said

court on this 22 nd day of December, 2014

.

_____________________________ Keith E. Hottle

Clerk of Court

1 This proceeding arises out of Cause No. 5924, styled The State of Texas v. Samuel Espinoza

, pending in the 229th

Judicial District Court, Duval County, Texas, the Honorable Ana Lisa Garza presiding.
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. 2197 Introduced in Senate (IS)]

<DOC>

116th CONGRESS
  1st Session
                                S. 2197

 To amend chapter 77 of title 18, United States Code, to clarify that 
  using drugs or illegal substances to cause a person to engage in a 
  commercial sex act constitutes coercion and using drugs or illegal 
   substances to provide or obtain the labor or services of a person 
                       constitutes forced labor.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             July 22, 2019

  Mr. Brown (for himself, Mr. Cornyn, Ms. Klobuchar, Mr. Portman, Mr. 
 Tillis, Mr. Blumenthal, and Mrs. Feinstein) introduced the following 
    bill; which was read twice and referred to the Committee on the 
                               Judiciary

_______________________________________________________________________

                                 A BILL

 
 To amend chapter 77 of title 18, United States Code, to clarify that 
  using drugs or illegal substances to cause a person to engage in a 
  commercial sex act constitutes coercion and using drugs or illegal 
   substances to provide or obtain the labor or services of a person 
                       constitutes forced labor.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Protecting Rights Of Those Exploited 
by Coercive Trafficking Act of 2019''.

SEC. 2. USE OF DRUGS OR ILLEGAL SUBSTANCES FOR TRAFFICKING IN PERSONS.

    (a) Forced Labor.--Section 1589(a) of title 18, United States Code, 
is amended--
            (1) in paragraph (3), by striking ``or'' at the end;
            (2) in paragraph (4), by striking the comma at the end and 
        inserting ``; or''; and
            (3) by inserting after paragraph (4) the following:
            ``(5) by means of supplying, furnishing, or providing any 
        drug or illegal substance to a person, including to exploit the 
        addiction of the person or cause the person to become addicted 
        to the drug or illegal substance,''.
    (b) Sex Trafficking.--Section 1591(e)(2) of title 18, United States 
Code, is amended--
            (1) in subparagraph (B), by striking ``or'' at the end;
            (2) in subparagraph (C), by striking the period at the end 
        and inserting ``; or''; and
            (3) by adding at the end the following:
                    ``(D) supplying, furnishing, or providing any drug 
                or illegal substance to a person, including to exploit 
                the addiction of the person or cause the person to 
                become addicted to the drug or illegal substance 
                (unless the defendant engaged in the conduct as a 
                direct result of being a victim of an offense under 
                this chapter).''.
                                 <all>
```
#### STATE v. ELLIOTT

No. 157 PC.

Case below: 41 N.C. App. 192.

Petition by defendant for discretionary review under G.S. 7A-31 denied 12 July 1979.
Case 1:07-cr-00366-JSR     Document 9      Filed 06/29/2007     Page 1 of 1
#### SHANKLE v. SHANKLE

No. 164 PC.

Case below: 23 N.C. App. 692.

Petition for writ of certiorari to North Carolina Court of Appeals allowed 4 February 1975.
#### STATE v. BLAND

No. 92 PC.

Case below: 34 N.C. App. 384.

Petition by defendant for discretionary review under G.S. 7A-31 denied 24 January 1978.
EX-4.9





 Exhibit 4.9 

Spousal Consent Letter 
 WHEREAS:

 1. I, Yang Qitao, a citizen of the People’s Republic of China, with the Identity Card Number of ***, is the spouse of Chen Rui who is a
shareholder of Shanghai Kuanyu Digital Technology Co., Ltd.; 
 2. Chen Rui has executed a series of agreements together with appendices and amendments
thereof in all forms with Hode Shanghai Limited and Shanghai Kuanyu Digital Technology Co., Ltd., including the “Equity Pledge Agreement”, the “Exclusive Technology Consulting and Services Agreement”, the “Exclusive Call
Option Agreement” and the “Power of Attorney” (the “Agreements”). 
 I hereby confirm that I have read and familiarize
myself with the provisions of the Agreements. I will be bound by the Agreements as a contracting party where necessary. 
 I further confirm and agree that:

  

	(1)	 The shares owned by Chen Rui referred to in the Agreements (“Chen Rui’s Shares”) remain
to be owned by Chen Rui in all circumstances whatsoever, and Chen Rui may pledge, sell or otherwise dispose of Chen Rui’s Shares in accordance with the provisions of the Agreements without my consent; 



 

	(2)	 Chen Rui may execute any amendments or variations to the Agreements with respect to Chen Rui’s Shares,
without the necessity to obtain my signature, confirmation, consent or affirmation; 


  

	(3)	 In no circumstances will I make any claim with respect to Chen Rui’s Shares or take any action that is
inconsistent with the provisions of the Agreements; 


  

	(4)	 Any part of Chen Rui’s Shares that may be attributable to myself (the “Owned Shares”)
shall be and are capable of being pledged, sold, or otherwise disposed of in accordance with the provisions of the Agreements; 


  

	(5)	 Where necessary, I agree to execute the Agreements as a contracting party, and undertake that any amendments or
variations to the Agreements will not be inconsistent in any way with the rights and obligations of Chen Rui under the Agreements. 


  

	(6)	 In no circumstances will I make any claim with respect to the Owned Shares or take any action that is
inconsistent with the provisions of the Agreements. 


 The above is hereby confirmed. 

 

			
	(Signature):	 	 /s/ Yang Qitao

		 	April 24, 2019
#### BETHEA v. BETHEA

No. 118 PC.

Case below: 43 N.C. App. 372.

Petition by defendant for discretionary review under G.S. 7A-31 denied 8 January 1980.
#### STATE v. BENNETT

No. 79 PC.

Case below: 11 N.C. App. 169.

Petition for writ of *certiorari*to North Carolina Court of Appeals denied 30 July 1971. Appeal dismissed *ex mero motu*for lack of substantial constitutional 'question 30 July 1971.
##### 



EXHIBIT 13.3 RECEIVABLES TRUSTEES OFFICERS CERTIFICATE GRACECHURCH RECEIVABLES TRUSTEE LIMITED
CERTIFICATE OF COMPLIANCE The undersigned officer of Gracechurch Receivables Trustee Limited, a private limited liability
company incorporated under the laws of Jersey, Channel Islands (the Receivables Trustee), hereby
certifies on behalf of the Receivables Trustee and on his own behalf for purposes of the Investor
Certificate, as follows: 1.
    
    I am a duly appointed, qualified and acting Director of the Receivables Trustee;2.
    
    I am duly authorized to execute and deliver this Officers Certificate on behalf of the Receivables Trustee; and3.
    
    To the best of my knowledge, the Receivables Trustee has complied with all conditions and covenants under the
Relevant Documents for the issue of the Investor Certificate for the period between January 1, 2004 and
December 31, 2004.
 Capitalized terms used and not defined herein shall have the meanings assigned to such terms in the
Registration Statement related to the above-referenced issue of Investor Certificate. IN WITNESS WHEREOF, I have signed my name this 30th day of June, 2005. By:
    
    /s/ Paul Gerard TurnerName:  Paul Gerard TurnerTitle:  Director
#### STATE v. PUCKETT

No. 102 PC.

No. 40 (Spring Term).

Case below: 43 N.C. App. 153.

Petition by defendant for discretionary review under G.S. 7A-31 allowed 4 December 1979. Notice of appeal of defendant dismissed.